Skip to main navigation

About Us
Our Approach
- Toll-Like Receptor Activation
- Publications & Presentations
Areas of Focus
- Immuno-Oncology
- Pipeline & Programs
Investor Relations
Investor Relations
Join Us

×

Investors

MainNavMenu

Investors and Media
Annual Meeting Materials
Analyst Coverage
Press Releases
Investor Events
Corporate Governance
Stock Information
SEC Filings
Investor Information
E-mail Alerts

Contact us

Please direct all questions regarding Idera to:

Idera Pharmaceuticals, Inc.
505 Eagleview Blvd, Suite 212
Exton, PA 19341

call (484) 348-1600
fax (484) 348-1670

info@iderapharma.com

Investor Tools

Press Releases

Latest Investor Presentation

January 2021 Corporate Presentation

Keyword Search

Year

Jan 11, 2021

Idera Pharmaceuticals to Present at Upcoming Conferences Read More

MainNavMenu

Investors and Media
Annual Meeting Materials
Analyst Coverage
Press Releases
Investor Events
Corporate Governance
Stock Information
SEC Filings
Investor Information
E-mail Alerts

Contact us

Please direct all questions regarding Idera to:

Idera Pharmaceuticals, Inc.
505 Eagleview Blvd, Suite 212
Exton, PA 19341

call (484) 348-1600
fax (484) 348-1670

info@iderapharma.com

Investor Tools

© 2021 Idera. All rights reserved.

Contact Us
Terms of Use
Privacy Policy

Share